Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- BEARN A. G. Genetic and biochemical aspects of Wilson's disease. Am J Med. 1953 Oct;15(4):442–449. doi: 10.1016/0002-9343(53)90134-x. [DOI] [PubMed] [Google Scholar]
- Cooper A. M., Eckhardt R. D., Faloon W. W., Davidson C. S. INVESTIGATION OF THE AMINOACIDURIA IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION): DEMONSTRATION OF A DEFECT IN RENAL FUNCTION. J Clin Invest. 1950 Mar;29(3):265–278. doi: 10.1172/JCI102254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DENNY-BROWN D., PORTER H. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease). N Engl J Med. 1951 Dec 13;245(24):917–925. doi: 10.1056/NEJM195112132452401. [DOI] [PubMed] [Google Scholar]
- Eden A., Green H. H. Micro-determination of copper in biological material. Biochem J. 1940 Sep;34(8-9):1202–1208. doi: 10.1042/bj0341202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GUBLER C. J., LAHEY M. E., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. IX. The transportation of copper in blood. J Clin Invest. 1953 May;32(5):405–414. doi: 10.1172/JCI102752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HOLMBERG C. G., LAURELL C. B. Oxidase reactions in human plasma caused by coeruloplasmin. Scand J Clin Lab Invest. 1951;3(2):103–107. doi: 10.3109/00365515109060581. [DOI] [PubMed] [Google Scholar]
- KUNKEL H. G., SLATER R. J. Zone electrophoresis in a starch supporting medium. Proc Soc Exp Biol Med. 1952 May;80(1):42–44. doi: 10.3181/00379727-80-19516. [DOI] [PubMed] [Google Scholar]
- LAHEY M. E., GUBLER C. J., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. VII. Blood copper in pregnancy and various pathologic states. J Clin Invest. 1953 Apr;32(4):329–339. doi: 10.1172/JCI102743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MATTHEWS W. B., MILNE M. D., BELL M. The metabolic disorder in hepato-lenticular degeneration. Q J Med. 1952 Oct;21(84):425–446. [PubMed] [Google Scholar]
- SCHEINBERG I. H., GITLIN D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952 Oct 31;116(3018):484–485. doi: 10.1126/science.116.3018.484. [DOI] [PubMed] [Google Scholar]
- SIDBURY J. B., Jr, BYNUM J. C., FETZ L. L. Effect of chelating agent on urinary lead excretion; comparison of oral and intravenous administration. Proc Soc Exp Biol Med. 1953 Feb;82(2):226–228. doi: 10.3181/00379727-82-20073. [DOI] [PubMed] [Google Scholar]
- STEIN W. H., BEARN A. G., MOORE S. The amino acid content of the blood and urine in Wilson's disease. J Clin Invest. 1954 Mar;33(3):410–419. doi: 10.1172/JCI102913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- UZMAN L. L., HOOD B. The familial nature of the amino-aciduria of Wilson's disease (hepatolenticular degeneration). Am J Med Sci. 1952 Apr;223(4):392–400. doi: 10.1097/00000441-195204000-00006. [DOI] [PubMed] [Google Scholar]